clopenthixol has been researched along with Parkinsonian Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PITHA, V; POLAK, O | 1 |
| AMDISEN, A; JENSEN, K | 1 |
| NUYTS, SA; SCHUNZELAAR, K; SEGERS, J | 1 |
| Dahl, ML; Jaanson, P; Kiivet, RA; Marandi, T; Svensson, JO; Vään, S; Vasar, V | 1 |
4 other study(ies) available for clopenthixol and Parkinsonian Disorders
| Article | Year |
|---|---|
PHARMACOLOGICAL PARKINSON'S SYNDROME.
Topics: Clopenthixol; Electromyography; Humans; Parkinson Disease; Parkinsonian Disorders; Phenothiazines; Tranquilizing Agents; Tremor | 1964 |
TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.
Topics: Clopenthixol; Double-Blind Method; Drug Therapy; Extrapyramidal Tracts; Haloperidol; Humans; Orphenadrine; Parasympatholytics; Parkinsonian Disorders; Perphenazine; Placebos; Tranquilizing Agents | 1964 |
REPORT ON THE TREATMENT OF PSYCHOTIC PATIENTS WITH SORDINOL.
Topics: Adolescent; Clopenthixol; Humans; Imipramine; Parkinsonian Disorders; Psychotic Disorders; Schizophrenia; Thiazines; Toxicology; Tranquilizing Agents | 1964 |
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
Topics: Adult; Aged; Analysis of Variance; Chi-Square Distribution; Clopenthixol; Confidence Intervals; Cytochrome P-450 CYP2D6; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Odds Ratio; Parkinsonian Disorders; Polymorphism, Genetic; Regression Analysis; Schizophrenia | 2002 |